Invivyd Inc
IVVD
NASDAQ
Biotechnology
$0.72
USD
+0.04 (+5.13%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $202.01M
Volume 2.0M
Price Target
$10.00 – $10.00
USD
The 2 analysts offering 1-year price forecasts have a max estimate of $10.00 and a min estimate of $10.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$10.00
Unchanged vs prior
Implied Upside
+1288.9%
Unchanged vs prior
Analyst Covering
2
+1 vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
67%
Most ratings are recent - from the last 3 months
Analyst Agreement
High
Targets are closely clustered - analysts largely agree
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
2 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
2 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Patrick R. Trucchio | HC Wainwright & Co. | Buy | Reiterated | 2 months ago | Plus | Plus | Plus |
Thomas Shrader | BTIG | Buy | Reiterated | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
NERV
Minerva Neurosciences Inc
$4.58
▲ +16.8%
KROS
Keros Therapeutics Inc
$10.10
▼ -5.3%
PEPG
PepGen Inc
$2.99
▲ +0.3%
KRRO
Korro Bio Inc
$13.28
▼ -0.1%
WHWK
Whitehawk Therapeutics Inc
$4.46
▼ -4.7%
NBP
NovaBridge Biosciences
$1.96
▲ +3.2%
TNXP
Tonix Pharmaceuticals Holding Corp
$12.71
▲ +1.7%
CRBP
Corbus Pharmaceuticals Holdings Inc
$10.09
▲ +0.1%
DTIL
Precision BioSciences Inc
$7.43
▲ +1.8%
RNA
Atrium Therapeutics Inc
$12.84
▲ +4.1%